GlaxoSmithKline dropping $95M to create research institute

http://www.bizjournals.com/philadelphia/blog/health-care/2015/06/glaxosmithkline-gsk-genome-research-institute.html?ana=e_du_pub&s=article_du&ed=2015-06-17&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1434642965

GlaxoSmithKline's building at the Philadelphia Navy Yard Corporate Center

Superbug threat prompts West to revisit Soviet-era virus therapy

http://www.reuters.com/article/2015/07/02/us-health-bacteriophages-insight-idUSKCN0PC1FO20150702

Two plates coated with drug-resistant bacteria with a mutation called NDM 1 and then exposed to various antibiotics are seen at the Health Protection Agency in north London, Britain in this March 9, 2011 file photo. REUTERS/Suzanne Plunkett/Files

Two plates coated with drug-resistant bacteria with a mutation called NDM 1 and then exposed to various antibiotics are seen at the Health Protection Agency in north London, Britain in this March 9, 2011 file photo.

PwC Infographic: Costs from specialty drugs skyrocket

PwC Infographic: Costs from specialty drugs skyrocket

PwC specialty drugs

A new PricewaterhouseCoopers report on medical cost trends highlights how specialty drugs are outpacing traditional drugs in a major way.

Novartis on digitizing medicine in an aging world

http://www.mckinsey.com/insights/leading_in_the_21st_century/Novartis_on_digitizing_medicine_in_an_aging_world?cid=ceointerview-eml-alt-mip-mck-oth-1506

Novartis on digitizing medicine in an aging world

CEO Joseph Jimenez explains where the company is placing its bets and how it’s seeking to bridge biology with technology.

Opinion: Investors should check up on health-care stocks

http://www.marketwatch.com/story/investors-should-check-up-on-health-care-stocks-2015-06-19

Type I diabetes cure? MGH researchers say new drug could be the answer

http://www.bizjournals.com/boston/blog/health-care/2015/06/type-i-diabetes-cure-mgh-researchers-say-new-drug.html?ana=e_du_wknd&s=article_du&ed=2015-06-13&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1434222298

Biotech Blue

New Push Ties Cost of Drugs to How Well They Work

http://www.wsj.com/articles/new-push-ties-cost-of-drugs-to-how-well-they-work-1432684755

Tarceva has shown a smaller benefit in pancreatic cancer than in lung cancer.

As drug costs rise, Express Scripts seeks new payment deals for some cancer medications

Pharma Trumps All Healthcare Sectors In Executive Compensation

http://www.forbes.com/sites/danmunro/2015/05/26/pharma-trumps-all-healthcare-sectors-in-executive-compensation/?utm_source=Sailthru&utm_medium=email&utm_term=Healthcare%20Dive&utm_campaign=Issue:%202015-05-26%20Healthcare%20Dive

Pharma1